BeStock  
Markets › Compare › EW vs ABT

EW vs ABT

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
EW · Edwards Lifesciences$85.21 ▼ 1.29%
ABT · Abbott Laboratories$97.46 ▼ 1.38%

Head to head

MetricEWABT
Price$85.21$97.46
Change today▼ 1.29%▼ 1.38%
Market cap$49.12B$168.65B
Return, 3 months–+6.5%
Return, year to date–-20.8%
Return, 1 year–-25.3%
P/E (TTM)49.531.5
P/B4.63.3
P/E percentile vs own 5y92nd69th
Dividend yield–2.50%
Revenue growth (YoY, latest qtr)+13.6%+13.0%
Net profit growth (YoY)-27.2%-47.8%
Gross margin77.8%56.6%
Operating margin28.1%15.8%
Net margin15.4%11.6%
Return on equity9.5%10.7%
Analyst target vs. price+21.3%+27.6%
Analyst buy share82%100%
RSI (14)–30
30-day volatility–20.3%
Max drawdown, 1 year–-38.6%
Trend read–Strong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • ABT is the largest of the group by market value.
  • ABT carries the lowest trailing P/E.
  • EW is growing revenue fastest.
  • EW keeps the most profit per dollar of sales.

Go deeper

Scroll to Top